ClinicalTrials.Veeva

Menu

Biological Evolution of Whipple's Disease (WHIP)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Whipple Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06776484
29BRC24.0315 - WHIP

Details and patient eligibility

About

Whipple's disease (WD), a rare systemic infection by Tropheryma whipplei, lacks research on biological abnormalities pre- and post-treatment. This study explores these abnormalities for their diagnostic and monitoring value.

Full description

Whipple's disease (WD) is a rare systemic infection caused by *Tropheryma whipplei*. Despite advancements in diagnosis through PCR and biopsy, there is limited research comparing biological abnormalities before and after treatment. This study aimed to characterize these abnormalities and evaluate their potential for aiding in diagnosis and monitoring.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with at least one positive PCR test for Whipple's disease and a retained diagnosis at Brest University Hospital between 2010 and 2024
  • Major patient

Exclusion criteria

  • Minors
  • No screening test for Whipple's disease
  • Opposition to participation
  • Protected patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems